Allergan Inks $750 Million Settlement with Namenda Purchasers
Purchasers of Allerganp-’s Namenda asked a federal decide Tuesday to approve a $750 million settlement of allegations that the drugmaker conspired to keep generic versions of the Alzheimer’s medicine off … Read More
